Market Overview

The Global Alopecia Treatment Market was valued at USD 9,327.6 million in 2023 and is expected to reach USD 19,279.0 million by 2031 while growing at a CAGR of 9.1% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global alopecia treatment market growth. Treatment for alopecia varies depending on its type, severity, and individual factors, with alopecia encompassing hair loss triggered by autoimmune conditions, hormonal fluctuations, genetics, and environmental influences.

The rising prevalence of alopecia, coupled with ongoing research and development efforts, drives the discovery of new treatment options such as topical solutions, oral medications, and minimally invasive procedures like hair transplants, propelling the alopecia treatment market forward. Nevertheless, the high cost of treatment and concerns regarding side effects and safety impede market growth.

Furthermore, the global alopecia treatment industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Technique Analysis

The Global Alopecia Treatment Market is segmented among Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, and Others, based on Technique. In 2023, Alopecia Areata accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Alopecia Treatment Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Stemson Therapeutics, OliX Pharmaceuticals, Inc, Pfizer Inc, Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy’s Laboratories Ltd., Himalaya Wellness Company, Stemson Therapeutics, Cosmo Pharmaceuticals N.V., Equillium, Inc., Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Alopecia Treatment Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Alopecia Treatment Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Alopecia Treatment Market Segmentation, By Technique

• Global Alopecia Treatment Market Share Analysis, By Technique

• Global Alopecia Treatment Market Growth Analysis, By Technique

• Global Alopecia Treatment Market Trends, By Technique

o Alopecia Areata

o Cicatricial Alopecia

o Traction Alopecia

o Alopecia Totalis

o Alopecia Universalis

o Androgenetic Alopecia

o Others

6. Global Alopecia Treatment Market Segmentation, By Distribution Channel

• Global Alopecia Treatment Market Share Analysis, By Distribution Channel

• Global Alopecia Treatment Market Growth Analysis, By Distribution Channel

• Global Alopecia Treatment Market Trends, By Distribution Channel

o Drugs

Ø OTC

Ø Prescription

o Devices

7. Global Alopecia Treatment Market Segmentation, By Region

• Global Alopecia Treatment Market Share Analysis, By Region

• Global Alopecia Treatment Market Growth Analysis, By Region

• Global Alopecia Treatment Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Stemson Therapeutics *

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• OliX Pharmaceuticals, Inc

• Pfizer Inc

• Aclaris Therapeutics, Inc.

• Fagron

• Follicum AB

• Cipla Inc.

• Arcutis Biotherapeutics

• Dr. Reddy’s Laboratories Ltd.

• Himalaya Wellness Company

• Stemson Therapeutics

• Cosmo Pharmaceuticals N.V.

• Equillium, Inc.

• Eli Lilly and Company

• Concert Pharmaceuticals Inc.

• Teva Pharmaceutical Industries Ltd.

*Similar analysis will be provided for each company listed above.